0161 504 8999
info@nasgp.org.uk
Clinical updates and guidelines for GP locums
A guideline from Nice recommends that omalizumab can be considered in chronic urticaria.
Are you confused about these new drugs and what can be used when? Here's a summary of which has what NICE approved.
© 2025 NASGP
Amelia House, Crescent Road, Worthing, BN11 1QR 0161 504 8999 info@nasgp.org.uk
Design by James Walker | Built by UnitedUs